Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 03, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today...
November 12, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx Reports Third Quarter 2025 Financial Results

REDWOOD CITY, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
October 27, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Glen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial...
October 15, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
August 26, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx to Participate in September Investor Conferences

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
July 30, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx Reports Second Quarter 2025 Financial Results

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
July 29, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
July 16, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

REDWOOD CITY, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
May 28, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
May 01, 2025 16:05 ET | Source: Pulmonx Corporation

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...